Edwards Lifesciences (NYSE:EW) Raised to “Overweight” at Piper Sandler
Edwards Lifesciences (NYSE:EW – Get Free Report) was upgraded by stock analysts at Piper Sandler from a “neutral” rating to an “overweight” rating in a research note issued on Thursday, Marketbeat Ratings reports. The firm currently has a $80.00 target price on the medical research company’s stock, up from their previous target price of $73.00. […]
Edwards Lifesciences (NYSE:EW – Get Free Report) was upgraded by stock analysts at Piper Sandler from a “neutral” rating to an “overweight” rating in a research note issued on Thursday, Marketbeat Ratings reports. The firm currently has a $80.00 target price on the medical research company’s stock, up from their previous target price of $73.00. […]
